These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33846154)

  • 1. Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort.
    Jantzen R; Payette Y; de Malliard T; Labbé C; Noisel N; Broët P
    BMJ Open; 2021 Apr; 11(4):e045078. PubMed ID: 33846154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
    Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
    Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating breast cancer risk projections for Hispanic women.
    Banegas MP; Gail MH; LaCroix A; Thompson B; Martinez ME; Wactawski-Wende J; John EM; Hubbell FA; Yasmeen S; Katki HA
    Breast Cancer Res Treat; 2012 Feb; 132(1):347-53. PubMed ID: 22147080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a genetic risk score for Arkansas women of color.
    Starlard-Davenport A; Allman R; Dite GS; Hopper JL; Spaeth Tuff E; Macleod S; Kadlubar S; Preston M; Henry-Tillman R
    PLoS One; 2018; 13(10):e0204834. PubMed ID: 30281645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk Models.
    Li SX; Milne RL; Nguyen-Dumont T; Wang X; English DR; Giles GG; Southey MC; Antoniou AC; Lee A; Li S; Winship I; Hopper JL; Terry MB; MacInnis RJ
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 33977228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
    Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
    Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
    Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
    Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.
    Powell M; Jamshidian F; Cheyne K; Nititham J; Prebil LA; Ereman R
    Clin Breast Cancer; 2014 Jun; 14(3):212-220.e1. PubMed ID: 24461459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.
    Pal Choudhury P; Wilcox AN; Brook MN; Zhang Y; Ahearn T; Orr N; Coulson P; Schoemaker MJ; Jones ME; Gail MH; Swerdlow AJ; Chatterjee N; Garcia-Closas M
    J Natl Cancer Inst; 2020 Mar; 112(3):278-285. PubMed ID: 31165158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENE.
    Jantzen R; Payette Y; de Malliard T; Labbé C; Noisel N; Broët P
    Prev Med Rep; 2022 Feb; 25():101678. PubMed ID: 35127357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry.
    Dite GS; MacInnis RJ; Bickerstaffe A; Dowty JG; Allman R; Apicella C; Milne RL; Tsimiklis H; Phillips KA; Giles GG; Terry MB; Southey MC; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):359-65. PubMed ID: 26677205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
    Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
    BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.
    Ghoncheh M; Ziaee F; Karami M; Poorolajal J
    Clin Breast Cancer; 2017 Jun; 17(3):e113-e118. PubMed ID: 28216418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Evaluation over 15 Years of Six Breast Cancer Risk Models.
    Li SX; Milne RL; Nguyen-Dumont T; English DR; Giles GG; Southey MC; Antoniou AC; Lee A; Winship I; Hopper JL; Terry MB; MacInnis RJ
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women.
    McCarthy AM; Armstrong K; Handorf E; Boghossian L; Jones M; Chen J; Demeter MB; McGuire E; Conant EF; Domchek SM
    Breast Cancer Res Treat; 2013 Apr; 138(3):889-98. PubMed ID: 23474973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.
    Quante AS; Whittemore AS; Shriver T; Hopper JL; Strauch K; Terry MB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25956172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of a breast cancer risk assessment tool by internal medicine residents in a primary care clinic: impact of an educational program.
    Yadav S; Hartkop S; Cardenas PY; Ladkany R; Halalau A; Shoichet S; Maddens M; Zakalik D
    BMC Cancer; 2019 Mar; 19(1):228. PubMed ID: 30871497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic risk scores for prediction of breast cancer in Korean women.
    Jee YH; Ho WK; Park S; Easton DF; Teo SH; Jung KJ; Kraft P
    Int J Epidemiol; 2023 Jun; 52(3):796-805. PubMed ID: 36343017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.
    Rudolph A; Song M; Brook MN; Milne RL; Mavaddat N; Michailidou K; Bolla MK; Wang Q; Dennis J; Wilcox AN; Hopper JL; Southey MC; Keeman R; Fasching PA; Beckmann MW; Gago-Dominguez M; Castelao JE; Guénel P; Truong T; Bojesen SE; Flyger H; Brenner H; Arndt V; Brauch H; Brüning T; Mannermaa A; Kosma VM; Lambrechts D; Keupers M; Couch FJ; Vachon C; Giles GG; MacInnis RJ; Figueroa J; Brinton L; Czene K; Brand JS; Gabrielson M; Humphreys K; Cox A; Cross SS; Dunning AM; Orr N; Swerdlow A; Hall P; Pharoah PDP; Schmidt MK; Easton DF; Chatterjee N; Chang-Claude J; García-Closas M
    Int J Epidemiol; 2018 Apr; 47(2):526-536. PubMed ID: 29315403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.